C7 antibody (AA 233-453) (FITC)
Quick Overview for C7 antibody (AA 233-453) (FITC) (ABIN7981442)
Target
See all C7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 233-453
-
Purpose
- Anti-Complement C7 Antibody FITC Conjugated
-
Specificity
- No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E. coli-derived human Complement C7 recombinant protein (Position: R233-D453).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- C7 (Complement Component C7 (C7))
-
Alternative Name
- C7
-
Background
-
Background: This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency.
Gene Full Name: complement C7
-
Gene ID
- 730
-
UniProt
- P10643
-
Pathways
- Complement System
Target
-